This document provides information about purchasing a 3Com TC1000-4E1-120-AC/DC device from Launch 3 Telecom. It describes the product, lists contact information for purchasing, and details payment and shipping options. It also outlines the warranty and additional services provided by Launch 3 Telecom such as repairs, maintenance contracts, and equipment de-installation.
This document outlines ideas for three video projects: a documentary about preserving the Le Genereux flag at Norwich Castle Museum; a narrative video following three people with sleep disorders to raise awareness from the nonprofit NANSA; and a documentary about the vision and plans for a new youth film club at Cinema City. It provides details on the concept, client, target audience, platforms, visual elements, locations, crew and equipment needed for each project.
Este documento describe las principales herramientas de la barra de herramientas de Microsoft Word, incluyendo botones para abrir, guardar y imprimir documentos, así como herramientas para copiar, cortar y pegar texto, deshacer acciones, y cambiar la fuente y apariencia de los documentos.
This document provides information about purchasing a 3Com TC1000-4E1-120-AC/DC device from Launch 3 Telecom. It describes the product, lists contact information for purchasing, and details payment and shipping options. It also outlines the warranty and additional services provided by Launch 3 Telecom such as repairs, maintenance contracts, and equipment de-installation.
This document outlines ideas for three video projects: a documentary about preserving the Le Genereux flag at Norwich Castle Museum; a narrative video following three people with sleep disorders to raise awareness from the nonprofit NANSA; and a documentary about the vision and plans for a new youth film club at Cinema City. It provides details on the concept, client, target audience, platforms, visual elements, locations, crew and equipment needed for each project.
Este documento describe las principales herramientas de la barra de herramientas de Microsoft Word, incluyendo botones para abrir, guardar y imprimir documentos, así como herramientas para copiar, cortar y pegar texto, deshacer acciones, y cambiar la fuente y apariencia de los documentos.
Cell el company presentation dec17 for website 17 jan18Eliyahu Schuman
Cell-El Ltd is developing a diagnostic kit for autism spectrum disorder (ASD) that uses proteomic and genetic biomarkers to enable early, objective diagnosis. The presentation outlines Cell-El's progress in collecting over 100 samples from children with ASD and controls to identify statistically significant biomarkers. If successful, the kit could allow for easier, earlier diagnosis of ASD compared to current behavioral methods, with the goal of facilitating early intervention. The team has published on immunological aspects of ASD and has an international network of experts collaborating on further research.
This editorial summarizes recent research on oncolytic viruses for cancer therapy. It discusses how oncolytic viruses can directly kill tumor cells and induce immune responses. Clinical trials have explored various naturally occurring and engineered viruses to treat cancers like melanoma, hepatocellular carcinoma, and glioblastoma. Recent FDA approval of the first oncolytic virus therapy for melanoma marks progress in the field. However, many questions remain regarding optimal viruses, combinations, dosages and administration methods. The role of the immune system is complex, with barriers and opportunities to leverage. Future work is needed to address challenges and maximize the potential of this innovative cancer treatment approach.
The document discusses four main strategies for monitoring the efficacy of oncolytic viruses via gene expression analysis: 1) analyzing overall gene expression in tumor cells before and after virus treatment, 2) looking at specific genes in tumor cells, 3) focusing on transgenes introduced into viruses, and 4) following viral gene expression. Several studies utilized these approaches in animal models and human cell lines. Gene expression changes provided insights into mechanisms like apoptosis, immune response, and signaling pathways affected. The most informative monitoring may integrate analysis of tumor cell and viral gene expression over time.
This document provides an overview of a research topic on oncolytic viruses for cancer therapy. It contains an introduction by the editors discussing the potential of genetically engineering oncolytic viruses and challenges that remain. The document then summarizes several articles in the research topic, focusing on specific viruses like adenovirus, herpes simplex virus, measles virus, and others. It also summarizes articles that focus on specific cancer applications and the role of the immune system in oncolytic virotherapy. The goal of the research topic is to advance the field of oncolytic viruses by exploring virus engineering, applications to specific cancers, and interactions with the immune system.
Cell el company presentation dec17 for website 17 jan18Eliyahu Schuman
Cell-El Ltd is developing a diagnostic kit for autism spectrum disorder (ASD) that uses proteomic and genetic biomarkers to enable early, objective diagnosis. The presentation outlines Cell-El's progress in collecting over 100 samples from children with ASD and controls to identify statistically significant biomarkers. If successful, the kit could allow for easier, earlier diagnosis of ASD compared to current behavioral methods, with the goal of facilitating early intervention. The team has published on immunological aspects of ASD and has an international network of experts collaborating on further research.
This editorial summarizes recent research on oncolytic viruses for cancer therapy. It discusses how oncolytic viruses can directly kill tumor cells and induce immune responses. Clinical trials have explored various naturally occurring and engineered viruses to treat cancers like melanoma, hepatocellular carcinoma, and glioblastoma. Recent FDA approval of the first oncolytic virus therapy for melanoma marks progress in the field. However, many questions remain regarding optimal viruses, combinations, dosages and administration methods. The role of the immune system is complex, with barriers and opportunities to leverage. Future work is needed to address challenges and maximize the potential of this innovative cancer treatment approach.
The document discusses four main strategies for monitoring the efficacy of oncolytic viruses via gene expression analysis: 1) analyzing overall gene expression in tumor cells before and after virus treatment, 2) looking at specific genes in tumor cells, 3) focusing on transgenes introduced into viruses, and 4) following viral gene expression. Several studies utilized these approaches in animal models and human cell lines. Gene expression changes provided insights into mechanisms like apoptosis, immune response, and signaling pathways affected. The most informative monitoring may integrate analysis of tumor cell and viral gene expression over time.
This document provides an overview of a research topic on oncolytic viruses for cancer therapy. It contains an introduction by the editors discussing the potential of genetically engineering oncolytic viruses and challenges that remain. The document then summarizes several articles in the research topic, focusing on specific viruses like adenovirus, herpes simplex virus, measles virus, and others. It also summarizes articles that focus on specific cancer applications and the role of the immune system in oncolytic virotherapy. The goal of the research topic is to advance the field of oncolytic viruses by exploring virus engineering, applications to specific cancers, and interactions with the immune system.